Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Todd Bosanac

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Journal of the American Chemical Society|April 19, 2002
A photoactivated precipiton for reagent sequestration in solution-phase synthesisTodd Bosanac, Craig S Wilcox
Organic Letters|July 2, 2004
Precipiton reagents: precipiton phosphines for solution-phase reductionsTodd Bosanac, Craig S Wilcox
Angewandte Chemie (International Ed. in English)|June 1, 2001
Precipitons-Functional Protecting Groups to Facilitate Product Separation: Applications in Isoxazoline SynthesisTodd Bosanac, Jaemoon Yang, Craig S. Wilcox
Journal of the American Chemical Society|November 14, 2007
Total synthesis of (-)-okilactomycinAmos B Smith, Kallol Basu, Todd Bosanac
Journal of the American Chemical Society|January 28, 2009
Evolution of the total synthesis of (-)-okilactomycin exploiting a tandem oxy-cope rearrangement/oxidation, a Petasis-Ferrier union/rearrangement, and ring-closing metathesisAmos B Smith, Todd Bosanac, Kallol Basu
Trends in Pharmacological Sciences|February 29, 2020
Axons Matter: The Promise of Treating Neurodegenerative Disorders by Targeting SARM1-Mediated Axonal DegenerationRaul Krauss, Todd Bosanac, Rajesh Devraj, et al.
Journal of Chemical Information and Modeling|August 10, 2017
Kinase Crystal Miner: A Powerful Approach to Repurposing 3D Hinge Binding Fragments and Its Application to Finding Novel Bruton Tyrosine Kinase InhibitorsPrasenjit Mukherjee, Jörg Bentzien, Todd Bosanac, et al.
Cell Reports|January 6, 2021
Small Molecule SARM1 Inhibitors Recapitulate the SARM1<sup>-/-</sup> Phenotype and Allow Recovery of a Metastable Pool of Axons Fated to DegenerateRobert O Hughes, Todd Bosanac, Xianrong Mao, et al.
Experimental Neurology|February 23, 2020
cADPR is a gene dosage-sensitive biomarker of SARM1 activity in healthy, compromised, and degenerating axonsYo Sasaki, Thomas M Engber, Robert O Hughes, et al.
Bioorganic & Medicinal Chemistry Letters|May 18, 2010
Substituted 2H-isoquinolin-1-ones as potent Rho-kinase inhibitors: part 3, aryl substituted pyrrolidinesTodd Bosanac, Eugene R Hickey, John Ginn, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Journal of the American Chemical Society|April 19, 2002
A photoactivated precipiton for reagent sequestration in solution-phase synthesisTodd Bosanac, Craig S Wilcox
Organic Letters|July 2, 2004
Precipiton reagents: precipiton phosphines for solution-phase reductionsTodd Bosanac, Craig S Wilcox
Angewandte Chemie (International Ed. in English)|June 1, 2001
Precipitons-Functional Protecting Groups to Facilitate Product Separation: Applications in Isoxazoline SynthesisTodd Bosanac, Jaemoon Yang, Craig S. Wilcox
Journal of the American Chemical Society|November 14, 2007
Total synthesis of (-)-okilactomycinAmos B Smith, Kallol Basu, Todd Bosanac
Journal of the American Chemical Society|January 28, 2009
Evolution of the total synthesis of (-)-okilactomycin exploiting a tandem oxy-cope rearrangement/oxidation, a Petasis-Ferrier union/rearrangement, and ring-closing metathesisAmos B Smith, Todd Bosanac, Kallol Basu
Trends in Pharmacological Sciences|February 29, 2020
Axons Matter: The Promise of Treating Neurodegenerative Disorders by Targeting SARM1-Mediated Axonal DegenerationRaul Krauss, Todd Bosanac, Rajesh Devraj, et al.
Journal of Chemical Information and Modeling|August 10, 2017
Kinase Crystal Miner: A Powerful Approach to Repurposing 3D Hinge Binding Fragments and Its Application to Finding Novel Bruton Tyrosine Kinase InhibitorsPrasenjit Mukherjee, Jörg Bentzien, Todd Bosanac, et al.
Cell Reports|January 6, 2021
Small Molecule SARM1 Inhibitors Recapitulate the SARM1<sup>-/-</sup> Phenotype and Allow Recovery of a Metastable Pool of Axons Fated to DegenerateRobert O Hughes, Todd Bosanac, Xianrong Mao, et al.
Experimental Neurology|February 23, 2020
cADPR is a gene dosage-sensitive biomarker of SARM1 activity in healthy, compromised, and degenerating axonsYo Sasaki, Thomas M Engber, Robert O Hughes, et al.
Bioorganic & Medicinal Chemistry Letters|May 18, 2010
Substituted 2H-isoquinolin-1-ones as potent Rho-kinase inhibitors: part 3, aryl substituted pyrrolidinesTodd Bosanac, Eugene R Hickey, John Ginn, et al.
Pageof 3